12 Health Care Stocks Moving In Thursday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Thursday's after-market session, several health care stocks experienced significant price movements. Bionomics, Lyell Immunopharma, and Edwards Lifesciences were among the top gainers, while DexCom, Quince Therapeutics, and Universal Health Services saw notable declines. The movements were influenced by Q3 earnings reports for some companies.
October 24, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Bionomics shares surged 48.3% to $0.53, significantly increasing its market value.
The substantial increase in Bionomics' stock price suggests positive investor sentiment or news, likely leading to short-term upward momentum.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Edwards Lifesciences shares rose 7.32% to $75.5 following Q3 earnings release.
The positive movement in Edwards Lifesciences' stock price is likely due to favorable Q3 earnings, suggesting short-term gains.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Lyell Immunopharma's stock rose by 32.92% to $1.45, reflecting a strong market response.
The significant rise in Lyell Immunopharma's stock price indicates positive developments or investor sentiment, likely boosting short-term performance.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
OneMedNet shares increased by 8.74% to $0.87, reflecting positive investor sentiment.
The increase in OneMedNet's stock price indicates positive market sentiment, likely leading to short-term upward movement.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Reviva Pharmaceuticals shares increased by 9.64% to $1.25, indicating positive market activity.
The rise in Reviva Pharmaceuticals' stock price suggests favorable market conditions or news, likely supporting short-term gains.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
DexCom stock fell 15.2% to $63.5 after Q3 earnings release, indicating negative market reaction.
The decline in DexCom's stock price suggests a negative market reaction to its Q3 earnings, likely leading to short-term downward pressure.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Quince Therapeutics stock declined by 14.29% to $1.02, reflecting negative investor sentiment.
The significant drop in Quince Therapeutics' stock price indicates negative sentiment or news, likely resulting in short-term declines.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Universal Health Services shares fell 10.98% to $200.0 after Q3 earnings release.
The decline in Universal Health Services' stock price suggests a negative market reaction to its Q3 earnings, likely leading to short-term downward pressure.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90